Medicamento para enfermedad de los riñones (Medications to treat kidney disease) - Joslin Receives $24.3 Million Grant from the NIH for Diabetic Kidney Disease Study

Medicamento para enfermedad de los riñones (Medications to treat kidney disease)




Narradora: Un médico responde
a la pregunta de un paciente.
¿Hay algún medicamento
para tratar la enfermedad
de los riñones?
Afortunadamente,
tenemos un par de medicamentos
que podemos utilizar
para ayudarle a sus riñones.
Estos medicamentos
generalmente se utilizan
para tratar la presión alta.
Hay pacientes que no tienen
presión alta
pero que tienen enfermedad
crónica de los riñones,
a los cuales nosotros
les damos esos medicamentos.
Estos medicamentos
protegen a los riñones
y ayudan a que la enfermedad
de los riñones no avance tanto,
tan rápidamente.
Así que, es importante
que usted tome sus medicinas
para ayudar a que sus riñones
se mantengan con buena función
por más tiempo.

https://www.youtube.com/watch?v=NHP0JZoPk60


Joslin Receives $24.3 Million Grant from the NIH for Diabetic Kidney Disease Study




people with diabetes
are at great risk for end-stage renal
disease. A new research project at Joslin
Diabetes Center
funded by a $25 million dollar NIH grant
will look for new ways to prevent this
Dr. Doria: the aim is to see whether by decreasing
uric acid in people who are at risk
of kidney complications really
can slow down or even halt
their progression to chronic kidney
disease and to end stage renal
disease.
Narration: this 8 Center clinical study
will be led by joslin's doctor Alessandro Doria
and the University of Minnesota's doctor
michael Mauer
other sites include Colorado Michigan
Chicago
New York Toronto Canada and Copenhagen
Denmark
Doria: the group is actually called PERL, which is Preventing Early Renal Loss
in Diabetes. The current estimates suggest that about
10 to 15 percent of people with diabetes
develop end stage renal disease meaning
that
they need either a renal transplant or
they need hemodialysis to survive
we need additionally intervention that
acts together
with good glycemic control, trying
to cub
diabetic complications.
Narration: The three-year
trial of approximately 500 people will
test if a generic drug called
allopurinol will reduce the occurrence
of kidney disease in people with type
1 diabetes
allopurinol has already been shown to
reduce uric acid levels
and has been on the market since the
1930s as a treatment for gout
Doria: we performed a fairly large study here
at the Joslin
this was done together with
Andrzej Krolewski in the same section
where I work
and basically what we did was to follow
a group of people with type 1
diabetes for several years and what
we saw was that the levels of uric acid
at the beginning of this study were
predictive of how quickly somebody would
lose kidney function
now this an association; we don't know
whether
there is a causal link but that's why we
are doing
this study to try to see whether by
decreasing uric acid actually we can
slow down this decline kidney function
hopefully
if this is a positive, if we have positive findings we'll have a new
intervention, so we'd have a new
therapy for a kidney
complications. But also by trying to understand the mechanisms
through which this happens might give us other
targets that we could act upon

https://www.youtube.com/watch?v=pUwRaUuY_vg